Midsummer is here and it is glorious! The daylight seems eternal, and it seems these endless days will last forever too. London is a city of light, with the sun bouncing off ten thousand windows. Is it even the same place as the London of six months ago? The further north you go, the […]
Rewind Therapeutics strengthens scientific advisory board with leading international neurology experts as it advances its first-in-class remyelination therapy Rewind Therapeutics, which is developing first-in-class treatments for demyelination-associated diseases, has appointed four internationally recognised innovators in neurology – Professors Shiv Saidha, Cristina Granziera, David Leppert, and Roberto Furlan – to its Scientific Advisory Board (SAB). The […]
Thursday June 12 was Global Fatty Liver Day. But until 2018 it was known as International NASH Day – NASH being short for ‘non-alcoholic steatohepatitis’. The name of the awareness day was changed to increase awareness of all types of fatty liver disease, as NASH is just one type – a more serious type – […]
SpliceBio secures $135 Million Series B financing to advance lead program SB-007 in Stargardt disease and expand pipeline of genetic medicines SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, announced the close of a $135 million Series B financing co-led by new investors EQT Life Sciences and Sanofi […]
Who can fail to have been impressed by the amazing developments in the field of oncology on display at ASCO 2025, everything from immunotherapies to ADCs to new biomarkers. But Optimum was struck by a number of studies which illustrate a challenge that isn’t clinical or technical, but vital, nonetheless. They were about trust. Over […]
